What is MetropolitanMD?
MetropolitanMD operates as a premier plastic surgery center, distinguished by the leadership of quadruple board-certified surgeon Dr. John Rachel. The practice provides a comprehensive suite of procedures, ranging from complex rhinoplasty and facelifts to advanced non-surgical interventions such as laser therapies and injectables. By integrating ENT services with aesthetic enhancements, the center occupies a unique niche that prioritizes both functional health and cosmetic outcomes. The facility is fully accredited, ensuring that patient safety and clinical precision remain at the forefront of its operational model. Through a patient-centered approach, the practice tailors every treatment plan to meet individual aesthetic goals, fostering long-term client loyalty and high satisfaction rates.
How much funding has MetropolitanMD raised?
MetropolitanMD has raised a total of $180K across 1 funding round:
Debt
$180K
Debt (2021): $180K with participation from PPP
Key Investors in MetropolitanMD
PPP
Public-Private Partnership
What's next for MetropolitanMD?
Looking ahead, the strategic deployment of this late-stage funding will likely focus on scaling operational capacity and potentially broadening the center's reach within the regional healthcare market. As the demand for high-quality, natural-looking aesthetic results continues to rise, MetropolitanMD is poised to invest in cutting-edge medical technology and talent acquisition to sustain its growth trajectory. The firm's focus on maintaining a modern, accredited facility suggests a continued emphasis on clinical excellence and patient experience. By optimizing its service delivery and potentially exploring new avenues in non-surgical aesthetic medicine, MetropolitanMD is set to reinforce its status as a leader in the facial plastic surgery sector, ensuring it remains at the vanguard of industry standards and patient care innovation.
See full MetropolitanMD company page
